Literature DB >> 16882081

Occipital condyle syndrome guiding diagnosis to metastatic prostate cancer.

Juan Ignacio Martinez Salamanca1, Concepcion Murrieta, Jose Jara, Jose Luis Munoz-Blanco, Federico Alvarez, Juan Guzman De Villoria, Carlos Hernandez.   

Abstract

Occipital condyle syndrome (OCS) results from a unilateral occipital pain associated with an ipsilateral paresis of the 12th cranial nerve (hypoglossal), and is typically caused by metastasis of the skull base. OCS diagnosis occurred, in all cases described in the published literature, when metastatic prostate cancer (MPC) was previously known. We present a case of a patient whose initial manifestation of MPC was OCS. The patient was treated with complete hormonal blockade and non-steroidal anti-inflammatory drugs as opposed to locoregional radiotherapy applied in other cases. After 18 month follow-up, the patient had a complete neurological and biochemical response.

Entities:  

Mesh:

Year:  2006        PMID: 16882081     DOI: 10.1111/j.1442-2042.2006.01466.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  4 in total

1.  Occipital condyle syndrome in a young male: a rare presentation of cranio-vertebral tuberculosis.

Authors:  Chaudhry Neera; Patidar Yogesh; Puri Vinod; Khwaja Geeta A
Journal:  J Clin Diagn Res       Date:  2014-11-20

2.  Occipital condyle syndrome: self diagnosed.

Authors:  Manoj Kumar Saraswat; Ranjit W Perera; Ian Renwick; Tadas Zuromskis; Vijay Singh; Edward Jones
Journal:  BMJ Case Rep       Date:  2009-03-17

3.  [Occipital condyle syndrome: the visible part of the iceberg].

Authors:  Amine Raggabi; Issam Lalya; Ahmed Bourazza
Journal:  Pan Afr Med J       Date:  2019-07-29

4.  Cranial nerve palsy caused by metastasis to the skull base in patients with castration-resistant prostate cancer: Three case reports.

Authors:  Yota Yasumizu; Takeo Kosaka; Hiroshi Hongo; Ryuichi Mizuno; Mototsugu Oya
Journal:  IJU Case Rep       Date:  2021-01-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.